Allotment Status
Registrar: KFintech
Issue price
₹140
Listing price
₹165.004
Last GMP (₹)
₹21.5
GMP estimate
+15.36%
Actual listing gain
+17.86%
Return per lot
+₹2,675.428
GMP vs listing performance
GMP pointed to +15.36% but the stock listed at +17.86% — 2.5% higher than estimated.
Listing gain calculator
Estimate profit or loss based on actual listing performance
Based on issue price ₹140 × 107 shares per lot. Listing price ₹165. Excludes taxes, DP charges, and selling costs.
Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this
Milky Mist Dairy Food IPO listed on 18 Aug 2026 at an issue price of ₹140, gained 17.9% on listing day. It delivered a moderate listing return. The issue was subscribed 2.29x overall.
Milky Mist Dairy Food is a recently listed Mainboard IPO in India, raising ₹1553.00 Cr, with shares offered around ₹140. The stock has listed with a +17.9% debut move versus the issue price. For business fundamentals, revenue trends, and use of proceeds, read the RHP on SEBI or NSE/BSE — we summarise market metrics, not audited financials.
GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 13 Aug 2026, 09:49 am IST. How we source data · Disclaimer
FAQ
The Milky Mist Dairy Food IPO allotment date is expected soon, following a strong subscription status. The grey market premium (GMP) of the issue has jumped to ₹29 from ₹23 after the bidding process ended. Investors can check their allotment status on the registrar's website or through the BSE website once it is announced.
Read full storyMilky Mist Dairy Food's IPO allotment is expected to be finalized today after receiving a 56.12-times subscription. The company's grey market premium (GMP) is currently at Rs 26, indicating a potential 19% listing gain. The shares are scheduled to list on the BSE and NSE on August 18.
Read full storyMilky Mist Dairy Food IPO has received attention on its third day, with the grey market premium (GMP) currently at ₹22. The subscription status is being closely watched by investors. The company's IPO is ongoing, with investors awaiting further updates on its progress.
Read full story